A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.
Also called NCT07754461
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 600 participants
- Sponsor
- Registry
-
NCT07754461
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Canada, India, New Zealand, Puerto Rico
- Registry status
- Recruiting
Technical summary
Registry record NCT07754461. Randomized; quadruple masking; primary purpose treatment. Start 2026-08-24 (actual); primary completion 2028-01-17 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Survodutide
- Lead sponsor
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct07754461- Content hash
250a49d6277052e2e41f298cd9b3a09209914cffff2efa5a0e64524cf705a999